GE Unit Ordered to Pay $5 Million Over Medical-Testing Dye
This article is for subscribers only.
A General Electric Co. unit must pay $5 million to an Ohio man who developed a skin disorder tied to the company’s Omniscan contrast agent used in medical tests, a jury ruled in the first verdict over the dye.
Jurors in federal court in Cleveland today found GE Healthcare Inc. liable for Paul Decker’s injuries from the Omniscan dye he received during 2005 tests on his heart, Christopher Tisi, one of Decker’s lawyers, said in a telephone interview. The dye caused an ailment that leads to a hardening of the skin and makes it difficult to move limbs, Tisi said.